LABORATORIOS FARMACEUTICOS ROVI, S.A. «...1112131415...» Page 14 out of 19 03/11/2021 07:36 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Register number: 12524 21/10/2021 18:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements La Sociedad informa sobre la realización de una aportación a las cuentas de efectivo y valores del Contrato de Liquidez Register number: 12297 21/10/2021 07:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Register number: 12278 07/10/2021 13:04 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Operaciones sobre acciones propias efectuadas en el tercer trimestre de 2021 en el marco del contrato de liquidez Register number: 12107 Notification modified by communication number 12000 dated 04/10/2021 (16:21) 04/10/2021 16:21 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Operaciones sobre acciones propias efectuadas en el tercer trimestre de 2021 en el marco del contrato de liquidez Register number: 12000 Notification modified by communication number 12107 dated 07/10/2021 (13:04) 02/09/2021 16:41 LABORATORIOS FARMACEUTICOS ROVI, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 11475 02/09/2021 16:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. General Shareholders’ Meeting Regulations La sociedad remite el Reglamento de la junta general de accionistas Register number: 11474 01/09/2021 21:34 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine. Register number: 11466 Related to communication no. 11399 dated 29/08/2021 (22:49) 29/08/2021 22:49 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan Register number: 11399 Related to communication no. 11377 dated 26/08/2021 (17:59) 26/08/2021 17:59 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation ROVI informs about the notification of particulate matter having been seen in certain drug product vials of the Moderna's COVID-19 vaccine distributed in Japan Register number: 11377 Page 14 out of 19 «...1112131415...»
